Poinciana Advisors Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,003
Closed -$273K 120
2024
Q4
$273K Buy
+2,003
New +$273K 0.28% 67